Who we are
Sepsis Research is known for backing ground-breaking research early – including the GenOMICC study, the only critical care or infectious disease genetics programme ever to lead directly to a new effective drug. Through seed funding, PhD studentships, new vaccines, diagnostics and innovative treatments, the charity bridges the gap between promising ideas and real-world impact, giving partners a central role in life-saving innovation.
Our work is shaped by lived experience, grounded in evidence and driven by the belief that better research leads to better diagnosis, treatment and recovery.
- Established in [year]
- Research projects funded
- Universities or institutions supported
- Invested in research to date
- 80p in every £1 spent on charitable aims
What you’ll find here
This section brings together the key pages that explain who Sepsis Research is, how the organisation is led and how support is used responsibly.
Why trust matters
People support charities they trust. That trust is built through clear leadership, transparent reporting, strong governance and visible commitment to impact.
The pages in this section show how Sepsis Research has grown from a deeply personal beginning into a focused, ambitious organisation working to put sepsis research where it belongs — at the centre of efforts to save lives and improve care.
Every discovery starts with someone willing to back an idea. When you support Sepsis Research, you help turn innovative beginnings into strong evidence – and strong evidence into better outcomes for patients and families facing sepsis.